Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients With Postpartum Depression (PPD)

NCT06342310 is registered in ClinicalTrials.gov with Reunion Neuroscience Inc as lead sponsor.

NCT NCT06342310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06342310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients With Postpartum Depression (PPD)
Lead sponsor
Reunion Neuroscience Inc
Phase
Phase 2
Overall status
Completed
Start date
June 14, 2024
Completion date
June 16, 2025
Enrollment
84 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum depression